Cargando…
Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
BACKGROUND: Evidence from both animal and human studies clearly supports the renal beneficial effects of empagliflozin (emp), a sodium glucose co-transporter 2 (SGLT2) inhibitor, but the mechanism in which it exerts its effect is not well understood. In this study, we investigated the capability of...
Autores principales: | Ndibalema, Angelamellisy Revelian, Kabuye, Deo, Wen, Si, Li, Lulu, Li, Xin, Fan, Qiuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297363/ https://www.ncbi.nlm.nih.gov/pubmed/32606855 http://dx.doi.org/10.2147/DMSO.S243170 |
Ejemplares similares
-
Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
por: Huang, Chiang-Chi, et al.
Publicado: (2021) -
No Cytotoxic and Inflammatory Effects of Empagliflozin and Dapagliflozin on Primary Renal Proximal Tubular Epithelial Cells under Diabetic Conditions In Vitro
por: Baer, Patrick C., et al.
Publicado: (2020) -
New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation
por: Sun, Hong, et al.
Publicado: (2022) -
Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells
por: Pirklbauer, Markus, et al.
Publicado: (2021) -
Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis
por: Bozic, Milica, et al.
Publicado: (2020)